Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Hypercholesterolaemia - familial
In the right clinical topic?

Age from 1 month onwards

This CKS topic is based on the National Institute for Health and Clinical Excellence (NICE) guideline, Identification and management of familial hypercholesterolaemia [NICE, 2008].

This CKS topic covers the detection and management in primary care of adults and children with homozygous or heterozygous familial hypercholesterolaemia (or familial primary type IIa hyperlipoproteinaemia).

This CKS topic does not cover the management of people with secondary hypercholesterolaemia, non-familial (polygenic) hypercholesterolaemia, combined hyperlipidaemia, hypertriglyceridaemia, type III hyperlipoproteinaemia, or sitosterolaemia (phytosterolaemia).

There are separate CKS topics on Antiplatelet treatment, CVD risk assessment and management, Hypertension - not diabetic, Lipid modification - CVD prevention, MI - secondary prevention, Obesity, and Smoking cessation.

The target audience for this CKS topic is healthcare professionals working within the NHS in England, and providing first contact or primary health care. Patient information from NHS Choices is intended to be printed and given to people with this condition or their carers.

© NHS Institute for Innovation and Improvement